Literature DB >> 10642538

Platelet-derived growth factor (PDGF)-induced activation of signal transducer and activator of transcription (Stat) 5 is mediated by PDGF beta-receptor and is not dependent on c-src, fyn, jak1 or jak2 kinases.

K Paukku1, S Valgeirsdóttir, P Saharinen, M Bergman, C H Heldin, O Silvennoinen.   

Abstract

Several growth factors activate signal transducers and activators of transcription (Stats) but the mechanism of Stat activation in receptor tyrosine kinase signalling has remained elusive. In the present study we have analysed the roles of different platelet-derived growth factor (PDGF)-induced tyrosine kinases in the activation of Stat5. Co-expression experiments in insect and mammalian cells demonstrated that both PDGF beta-receptor (PDGF beta-R) and Jak1, but not c-Src, induced the activation of Stat5. Furthermore, immune-complex-purified PDGF beta-R was able to phosphorylate Stat5 directly. The role of the cytoplasmic tyrosine kinases in the PDGF-induced activation of Stat5 was further investigated by overexpressing kinase-negative (KN) and wild-type Jak and c-Src kinases. Jak1-KN or Jak2-KN had no effect but both Src-KN and wild-type c-Src similarly decreased the PDGF-beta-R-induced activation of Stat5. The activation of both Src and Stat5 is dependent on the same tyrosine residues Tyr(579) and Tyr(581) in PDGF beta-R; thus the observed inhibition by Src might result from competition for binding of Stat5 to the receptor. Finally, fibroblasts derived from Src(-/-) and Fyn(-/-) mice showed normal pattern of PDGF-induced tyrosine phosphorylation of Stat5. Taken together, these results indicate that Stat5 is a direct substrate for PDGF beta-R and that the activation does not require Jak1, Jak2, c-Src or Fyn tyrosine kinases.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10642538      PMCID: PMC1220814     

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  42 in total

1.  Activation and association of Stat3 with Src in v-Src-transformed cell lines.

Authors:  X Cao; A Tay; G R Guy; Y H Tan
Journal:  Mol Cell Biol       Date:  1996-04       Impact factor: 4.272

2.  The effect of platelet-derived growth factor and adipogenic hormones on the expression of CCAAT/enhancer-binding proteins in 3T3-L1 cells in serum-free conditions.

Authors:  M Bachmeier; G Löffler
Journal:  Eur J Biochem       Date:  1997-01-15

3.  Platelet-derived growth factor induces phosphorylation of multiple JAK family kinases and STAT proteins.

Authors:  M L Vignais; H B Sadowski; D Watling; N C Rogers; M Gilman
Journal:  Mol Cell Biol       Date:  1996-04       Impact factor: 4.272

4.  Targeted disruption of the mouse Stat3 gene leads to early embryonic lethality.

Authors:  K Takeda; K Noguchi; W Shi; T Tanaka; M Matsumoto; N Yoshida; T Kishimoto; S Akira
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-15       Impact factor: 11.205

5.  Stat6 is required for mediating responses to IL-4 and for development of Th2 cells.

Authors:  M H Kaplan; U Schindler; S T Smiley; M J Grusby
Journal:  Immunity       Date:  1996-03       Impact factor: 31.745

6.  Constitutive activation of JAK1 in Src-transformed cells.

Authors:  G S Campbell; C L Yu; R Jove; C Carter-Su
Journal:  J Biol Chem       Date:  1997-01-31       Impact factor: 5.157

7.  Stat5 is a physiological substrate of the insulin receptor.

Authors:  J Chen; H B Sadowski; R A Kohanski; L H Wang
Journal:  Proc Natl Acad Sci U S A       Date:  1997-03-18       Impact factor: 11.205

8.  Targeted disruption of the mouse Stat1 gene results in compromised innate immunity to viral disease.

Authors:  J E Durbin; R Hackenmiller; M C Simon; D E Levy
Journal:  Cell       Date:  1996-02-09       Impact factor: 41.582

9.  Phosphorylation and activation of the DNA binding activity of purified Stat1 by the Janus protein-tyrosine kinases and the epidermal growth factor receptor.

Authors:  F W Quelle; W Thierfelder; B A Witthuhn; B Tang; S Cohen; J N Ihle
Journal:  J Biol Chem       Date:  1995-09-01       Impact factor: 5.157

10.  Kinase-negative mutants of JAK1 can sustain interferon-gamma-inducible gene expression but not an antiviral state.

Authors:  J Briscoe; N C Rogers; B A Witthuhn; D Watling; A G Harpur; A F Wilks; G R Stark; J N Ihle; I M Kerr
Journal:  EMBO J       Date:  1996-02-15       Impact factor: 11.598

View more
  19 in total

1.  Identification of p100 as a coactivator for STAT6 that bridges STAT6 with RNA polymerase II.

Authors:  Jie Yang; Saara Aittomäki; Marko Pesu; Kara Carter; Jussi Saarinen; Nisse Kalkkinen; Elliott Kieff; Olli Silvennoinen
Journal:  EMBO J       Date:  2002-09-16       Impact factor: 11.598

2.  Immunohistochemical detection of phosphorylated JAK-2 and STAT-5 proteins and correlation with erythropoietin receptor (EpoR) expression status in human brain tumors.

Authors:  M Kondyli; G Gatzounis; A Kyritsis; J Varakis; M Assimakopoulou
Journal:  J Neurooncol       Date:  2010-03-25       Impact factor: 4.130

3.  The Src family kinase Hck couples BCR/ABL to STAT5 activation in myeloid leukemia cells.

Authors:  Agata Klejman; Steven J Schreiner; Malgorzata Nieborowska-Skorska; Artur Slupianek; Matthew Wilson; Thomas E Smithgall; Tomasz Skorski
Journal:  EMBO J       Date:  2002-11-01       Impact factor: 11.598

4.  Signal transducers and activators of transcription-3 binding to the fibroblast growth factor receptor is activated by receptor amplification.

Authors:  Anna A Dudka; Steve M M Sweet; John K Heath
Journal:  Cancer Res       Date:  2010-04-13       Impact factor: 12.701

5.  STAT 5a expression in various lesions of the breast.

Authors:  Gary L Bratthauer; Brian L Strauss; Fattaneh A Tavassoli
Journal:  Virchows Arch       Date:  2005-08-19       Impact factor: 4.064

6.  Progestins induce transcriptional activation of signal transducer and activator of transcription 3 (Stat3) via a Jak- and Src-dependent mechanism in breast cancer cells.

Authors:  Cecilia Proietti; Mariana Salatino; Cinthia Rosemblit; Romina Carnevale; Adalí Pecci; Alberto R Kornblihtt; Alfredo A Molinolo; Isabel Frahm; Eduardo H Charreau; Roxana Schillaci; Patricia V Elizalde
Journal:  Mol Cell Biol       Date:  2005-06       Impact factor: 4.272

7.  Multiple oligomerization domains of KANK1-PDGFRβ are required for JAK2-independent hematopoietic cell proliferation and signaling via STAT5 and ERK.

Authors:  Sandrine Medves; Laura A Noël; Carmen P Montano-Almendras; Roxana I Albu; Hélène Schoemans; Stefan N Constantinescu; Jean-Baptiste Demoulin
Journal:  Haematologica       Date:  2011-06-17       Impact factor: 9.941

8.  Mechanisms of STAT protein activation by oncogenic KIT mutants in neoplastic mast cells.

Authors:  Amandine Chaix; Sophie Lopez; Edwige Voisset; Laurent Gros; Patrice Dubreuil; Paulo De Sepulveda
Journal:  J Biol Chem       Date:  2010-12-06       Impact factor: 5.157

9.  The Fer tyrosine kinase is important for platelet-derived growth factor-BB-induced signal transducer and activator of transcription 3 (STAT3) protein phosphorylation, colony formation in soft agar, and tumor growth in vivo.

Authors:  Johan Lennartsson; Haisha Ma; Piotr Wardega; Karin Pelka; Ulla Engström; Carina Hellberg; Carl-Henrik Heldin
Journal:  J Biol Chem       Date:  2013-04-15       Impact factor: 5.157

Review 10.  STAT5a/b contribute to sex bias in vascular disease: A neuroendocrine perspective.

Authors:  Pravin B Sehgal; Yang-Ming Yang; Huijuan Yuan; Edmund J Miller
Journal:  JAKSTAT       Date:  2015-09-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.